Epigenetic Silencing Mediates Mitochondria Stress-Induced Longevity  by Schroeder, Elizabeth A. et al.
Cell Metabolism
ArticleEpigenetic Silencing Mediates
Mitochondria Stress-Induced Longevity
Elizabeth A. Schroeder,1,2 Nuno Raimundo,1 and Gerald S. Shadel1,2,*
1Department of Pathology
2Department of Genetics
Yale University School of Medicine, New Haven, CT 06520, USA
*Correspondence: gerald.shadel@yale.edu
http://dx.doi.org/10.1016/j.cmet.2013.04.003SUMMARY
Reactive oxygen species (ROS) play complex roles in
aging, having both damaging effects and signaling
functions. Transiently elevatingmitochondrial stress,
including mitochondrial ROS (mtROS), elicits benefi-
cial responses that extend lifespan. However, these
adaptive, longevity-signaling pathways remain
poorly understood. We show here that Tel1p and
Rad53p, homologs of the mammalian DNA damage
response kinases ATMandChk2,mediate a hormetic
mtROS longevity signal that extends yeast chrono-
logical lifespan. This pathway senses mtROS in a
manner distinct from the nuclear DNA damage
response and ultimately imparts longevity by inacti-
vating the histone demethylase Rph1p specifically
at subtelomeric heterochromatin, enhancing binding
of the silencing protein Sir3p, and repressing subte-
lomeric transcription. These results demonstrate
the existence of conserved mitochondria-to-nucleus
stress-signaling pathways that regulate aging
through epigenetic modulation of nuclear gene
expression.
INTRODUCTION
As multifunctional organelles, mitochondria influence aging, life-
span, and healthspan through a variety of mechanisms. Perhaps
the most recognized is the production of reactive oxygen spe-
cies (ROS), byproducts of mitochondrial respiration that damage
macromolecules to promote cell dysfunction, apoptosis, and ag-
ing (Balaban et al., 2005). However, ROS also function as
signaling molecules that regulate physiological processes (Fin-
kel, 2011; Sena and Chandel, 2012) and participate in conserved
signal transduction pathways, including the target of rapamycin
(TOR) and insulin-sensing pathways that regulate longevity
(Longo et al., 2012; Pan et al., 2011; Raimundo et al., 2012; Zarse
et al., 2012). Additionally, studies in model organisms show that
increasing ROS levels can positively influence health- and life-
span (Lee et al., 2010; Pan et al., 2011; Schulz et al., 2007;
Yang and Hekimi, 2010; Zarse et al., 2012).
Chronological lifespan (CLS) of the budding yeast, Saccha-
romyces cerevisiae, is measured by assaying the amount of954 Cell Metabolism 17, 954–964, June 4, 2013 ª2013 Elsevier Inc.time that cells survive in the late post-diauxic and stationary
phases of culturing that follow exponential growth (Longo
et al., 2012). Yeast CLS studies, which model postmitotic
cellular aging in higher eukaryotes, have led to the identifica-
tion of conserved pathways and processes involved in lifespan
regulation (Fabrizio and Longo, 2007; Kaeberlein, 2010; Longo
et al., 2012). We recently demonstrated that elevating mito-
chondrial ROS (mtROS) during yeast exponential growth
elicits an adaptive response that reduces ROS in post-diauxic
and stationary phases and extends CLS (Pan et al., 2011).
Interventions that elevate mtROS in C. elegans also extend
lifespan (Lee et al., 2010; Schulz et al., 2007; Yang and
Hekimi, 2010; Zarse et al., 2012), and exercise in mammals
is believed to improve health via increasing mtROS (Ristow
et al., 2009). These examples indicate that hormetic adap-
tation to ROS is an emerging paradigm in lifespan and health-
span regulation (Gems and Partridge, 2008; Ristow and
Schmeisser, 2011; Tapia, 2006). However, the signaling path-
ways that sense ROS and coordinate hormetic changes in
cellular function to curtail aging and promote longevity remain
largely unknown.
Hormetic ROS might extend lifespan by increasing stress
resistance or decreasing ROS levels late in life (Gems and Par-
tridge, 2008). However, other cellular processes may be targets
of mtROS signaling. In particular, aspects of telomere function
determine replicative capacity and impact lifespan (Blasco,
2005). In yeast, telomeres consist of a repetitive TG1–3 sequence
bound by several highly conserved proteins that regulate telo-
mere length, transcription, and packaging (Grunstein, 1997).
The silent information regulator (Sir) proteins maintain telomeric
heterochromatin to repress transcription (Rusche et al., 2003).
Histone modifications adjacent to telomeres regulate the spread
of silencing, termed telomere position effect (TPE), by enhancing
or preventing Sir complex binding (Altaf et al., 2007; Dang et al.,
2009; Kozak et al., 2010; Park and Lustig, 2000). Yeast impaired
in specific histone modifications that support TPE have a shorter
replicative lifespan (Dang et al., 2009), and decreased hetero-
chromatin formation at telomeres and subtelomeres inmammals
induces telomere dysfunction to trigger apoptosis or senes-
cence (Blasco, 2007). However, the signaling pathways that
regulate histone modifications to support subtelomeric silencing
are not fully understood. Additionally, although substantial prog-
ress has been made toward understanding the relationships
between telomere dysfunction and replicative lifespan, how
telomere function might influence postmitotic aging remains
unknown.
Figure 1. The Histone Demethylase Rph1p
Mediates Hormetic mtROS Longevity
Signaling
(A) Strategy to identify factors that regulate the
global transcriptional response to hormetic
mtROS signaling. (i) Identification of genes
induced under conditions of elevated mtROS. (ii)
Promoter sequences of induced genes were
analyzed to identify enriched motifs. (iii) Known
transcription factor binding sequences were
scanned for the presence of motifs similar to those
enriched in mtROS-induced gene promoters.
(B) Results of promoter analysis. The AG5 motif is
significantlyenriched inpromotersofgenes induced
by mtROS and is similar to the DNA sequences
recognized by the proteins listed. The percentages
of mtROS-induced genes containing the exact
motifs recognized by the candidate proteins are
indicated to the right of themotif. See also Table S1.
(C) CLS of wild-type (DBY2006) and rph1D strains
treated with 50 mMmenadione (MD) or vehicle (not
treated, nt) during logarithmic growth. In all CLS
curves, data points represent the mean of three
biological replicates inoculated from single
colonies ± SEM.
(D) ROS levels in wild-type and rph1D strains
treated with menadione (MD+) or vehicle () dur-
ing exponential growth. Samples were analyzed at
day 1 of CLS. In all graphs, data points represent
the mean of three biological replicates ± SEM
unless otherwise indicated. ‘‘ns’’ designates p >
0.05, *p % 0.05, and **p% 0.01.
(E)RT-PCRof transcripts inducedbymtROS.Wild-
type and rph1D were treated with 50 mM mena-
dione (MD) or vehicle (nt) for 2 hr in exponential
phase, and the expression of three genes selected
from the list of 45 mtROS-responsive transcripts
(Figure 1A) was analyzed. See also Figure S1.
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Mitochondrial ROS Signal Epigenetic AdaptationHerein, we focused on the process of hormetic mtROS
signaling and adaptation in yeast, reasoning that our studies
would reveal conserved mechanisms of ROS sensing and
longevity regulation. We show that mtROS signal via Tel1p
and Rad53p, homologs of mammalian ATM and Chk2, uncov-
ering a function for the DNA damage response in communi-
cating mitochondria functional status to the nucleus. This
signaling pathway inhibits the histone demethylase Rph1p spe-
cifically at subtelomeric regions, which enhances transcrip-
tional silencing to extend CLS. In yeast and mammals, telomere
dysfunction signals changes in mitochondrial biogenesis and
function (Nautiyal et al., 2002; Sahin et al., 2011). Thus, our re-
sults demonstrate that two-way communication pathways exist
between mitochondria and telomeres that regulate aging and
longevity.Cell Metabolism 17, 954–RESULTS
The H3K36 Demethylase Rph1p
Mediates Hormetic Responses to
mtROS
Reduced TOR complex 1 (TORC1)
signaling extends lifespan in many
model organisms (Kenyon, 2005), andwe showed previously that mtROS hormesis contributes to
this mode of CLS extension in yeast (Pan et al., 2011). Further-
more, transient treatment with a sublethal dose of the redox-
cycling compound menadione during exponential growth gen-
erates mtROS (Castro et al., 2008) and extends yeast CLS (Pan
et al., 2011) (Figure S1A). Menadione treatment and reduced
TORC1 signaling decrease cellular ROS levels in post-diauxic
and stationary phases, supporting that hormetic adaptation to
ROS occurs under these conditions (Bonawitz et al., 2007;
Pan et al., 2011). To identify factors that mediate mtROS
longevity signaling, we crossed the results of two published mi-
croarrays from conditions that increase mtROS in yeast (1 mM
menadione and 100 nm rapamycin, a TORC1 inhibitor) and
identified the commonly induced genes (Figure 1Ai and Table
S1) (Gasch et al., 2000; Hardwick et al., 1999). Rather than964, June 4, 2013 ª2013 Elsevier Inc. 955
Figure 2. A Mitochondrial Superoxide
Signal Extends CLS
(A) Western blot analysis of Sod2p (MnSOD) in
PTDH::SOD2 and wild-type (DBY2006). Samples
were collected at an OD600 of 1.0. MnSOD band
intensity was normalized to actin, and the
DBY2006 protein level was set to 1. Values under
the blot represent the mean ± SEM for three bio-
logical replicates.
(B) CLS in wild-type and PTDH::SOD2 strains
following exponential phase treatment with
menadione (MD) or ethanol (nt).
(C) CLS in wild-type and sod2D strains as in (B).
(D) CLS in wild-type and rho as in (B).
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not show individual robust contributions to mtROS adaptation,
we searched first for transcriptional regulators that globally
coordinate these gene expression responses and second for
signaling events that determine their activity (Figures 1Aii,
1Aiii, and S1B). We identified a promoter motif, AG5, enriched
in these genes (Figure 1B) (Romer et al., 2007) and transcrip-
tional regulators that bind motifs similar to AG5 (Abdulrehman
et al., 2011). Candidate transcriptional regulators included
Gis1p and Msn2p/Msn4p, which have known roles in oxidative
stress resistance, nutrient sensing, and CLS (Wei et al., 2008).
Strains lacking Msn2p or Msn4p demonstrated a moderately
reduced adaptive CLS response relative to the wild-type
strain (72% and 81% of the menadione-dependent CLS exten-
sion observed in wild-type; Figures S1C and S1D), indicating
nonredundant contributions of each transcription factor.
Combined deletion of MSN2 and MSN4 abrogated mena-
dione-induced CLS extension to 53% of that observed in the
wild-type strain (Figure S1E). This additive effect suggests
that Msn2p and Msn4p have partially redundant functions in
mtROS adaptation, consistent with their overlapping regulation
of gene expression in response to stress and downstream of
TORC1 signaling (Gasch et al., 2000; Wei et al., 2008, 2009).
Deletion of GIS1 reduced menadione-dependent CLS
extension to 47% of the response seen in the wild-type
(Figure S1F), indicating that it also participates in mtROS adap-
tation. Gis1p and Msn2p/Msn4p cooperatively contribute to
yeast CLS extension under conditions of reduced TORC1
signaling and caloric restriction (Wei et al., 2008). However,
a gis1D/msn2D/msn4D mutant strain retained an adaptive
CLS response that was 47% of wild-type (Figure S1G), iden-
tical to that of the gis1D single mutant. This epistatic relation-
ship indicates that Gis1p, Msn2p, and Msn4p partially
contribute to the mtROS adaptive response in the same ge-
netic pathway. Only deletion of the histone 3 lysine 36956 Cell Metabolism 17, 954–964, June 4, 2013 ª2013 Elsevier Inc.(H3K36) demethylase Rph1p completely
abrogated CLS extension (Figure 1C),
eliminated the hormetic decrease in
ROS at day 1 of CLS (Figure 1D), and
impaired expression of mtROS-respon-
sive genes (Figure 1E). Rph1p also
contributed to the CLS extension
observed in a tor1D strain (Figure S1H),
consistent with Rph1p participating inTORC1-regulated mtROS hormesis (Pan et al., 2011). Intrigued
by the notion that mtROS adaptation might involve epigenetic
changes in nuclear gene expression, Rph1p became our pri-
mary focus.
Hormetic Menadione Treatment Induces Mitochondria
Superoxide to Extend CLS
Overexpression of SOD2, which encodes the mitochondria
matrix superoxide dismutase, curtails CLS extension in tor1D
yeast, supporting that elevated mtROS initiates an adaptive
signal (Pan et al., 2011). To determine if hormetic menadione
treatment elicits adaptive responses via a similar mechanism,
we measured CLS in strains with different mtROS detoxification
capacities. We utilized a strain in which the strong TDH3 pro-
moter (Ko¨tter et al., 2009) drives SOD2 expression (PTDH-
SOD2) (Figure 2A) and a sod2D strain, with increased or
decreased mtROS detoxification capabilities, respectively. The
PTDH-SOD2 strain demonstrated reduced CLS extension relative
to the wild-type strain (Figure 2B). In contrast, sod2D amplified
CLS extension (Figure 2C). Menadione treatment also failed to
extend CLS in a rho strain, which lacks mitochondrial DNA
(mtDNA), and hence is unable to respire (Figure 2D). We there-
fore conclude that menadione is affecting CLS via alteration of
mtROS levels (i.e., superoxide).
Tel1p and Rad53p, Components of the Nuclear DNA
Damage Response, Contribute to mtROS Hormesis
The DNA damage checkpoint kinase Rad53p (Chk2 in mam-
mals) phosphorylates Rph1p in response to DNA damage
(Kim et al., 2002) (Figure 3A). Subsequent Rph1p-mediated
chromatin modifications permit transcription of the DNA repair
enzyme PHR1 (Liang et al., 2011). Mec1p (ATR in mammals)
activates and phosphorylates Rad53p (Pellicioli et al., 1999),
and phosphorylation of Rph1p in response to DNA damage is
Mec1p dependent (Kim et al., 2002); therefore, we investigated
Figure 3. Hormetic mtROS Longevity
Signaling Requires the Tel1p and Rad53p
DNA Damage Response Kinases
(A) Schematic of DNA damage signaling in
Saccharomyces cerevisiae.
(B) CLS of sml1D and rad53D/sml1D strains
treated with 50 mMmenadione (MD) or vehicle (nt)
during exponential growth.
(C) ROS levels in sml1D and rad53D/sml1D strains
treated with menadione (+) or vehicle () during
exponential growth as in Figure 1D. Samples were
collected at day 1 of CLS.
(D) CLS of wild-type (DBY2006) and tel1D strains
as in (B). See also Figure S2.
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signaling. Deletion of SML1 suppressed the lethality of rad53D
and mec1D and allowed us to examine their role in mtROS
signaling and adaptation (Zhao et al., 1998). Although
Rad53p was required for mtROS-mediated CLS extension (Fig-
ure 3B) and hormetic reduction of ROS at day 1 of CLS (Fig-
ure 3C), Mec1p was not (Figure S2A). Therefore, we investi-
gated the involvement of the related kinase Tel1p, which has
partially overlapping functions with Mec1p (Figure 3A) but
unique roles in telomere maintenance (Harrison and Haber,
2006). Additionally, the mammalian homolog of Tel1p, ATM,
senses ROS (Guo et al., 2010), making Tel1p an attractive
candidate to mediate mtROS signaling in yeast. Menadione
treatment did not extend CLS in a tel1D strain (Figure 3D),
implicating Tel1p as an upstream kinase in the adaptive mtROS
pathway. The lack of adaptation to mtROS in rph1D, rad53D,
and tel1D strains is not due to endogenous differences in
ROS levels or an inability of these strains to elevate mtROS
upon menadione treatment during exponential growth (Fig-
ure S2B). Thus far, these results indicate that Tel1p, Rad53p,
and Rph1p together mediate mtROS signaling and adaptation
to extend yeast CLS.
Hormetic Menadione Treatment Activates DNA
Damage-Responsive Kinases in the Absence of Nuclear
DNA Damage
Tel1p phosphorylates Rad53p upon telomere dysfunction or
DNA damage (Sanchez et al., 1996). Hormetic menadione treat-
ment caused an upward mobility shift in Rad53p, but this shift
was intermediate to that observed following treatment with a
comparable dose of methylmethane sulfate (MMS), a direct
DNA damaging agent (Figures 4A, left, and S3A–S3C). The
menadione-induced mobility shift was abolished by phospha-Cell Metabolism 17, 954–tase treatment and did not occur in a
tel1D strain, yet MMS-induced Rad53p
phosphorylation was not affected by
tel1D (Figure 4A, right). Rad53p contains
multiple Tel1p/Mec1p target phosphory-
lation sites, characterized by an (S/T)Q
motif (Kim et al., 1999; Lee et al.,
2003). Analysis of (S/T)Q phosphoprotein
profiles revealed that hormetic mena-
dione treatment induced phosphoryla-
tion of a specific subset of (S/T)Q-con-taining targets compared to an MMS treatment that had
similar effects on cell growth and toxicity (Figure 4B). This
distinct profile, combined with partial phosphorylation
of Rad53p in response to menadione, indicated to us that
hormetic mtROS signaling via Tel1p and Rad53p is distinct
from canonical Mec1p-mediated DNA damage signaling.
We additionally demonstrated that the transcriptional outcomes
of hormetic mtROS signaling are distinct from a DNA damage
transcriptional signature (DDTS), which corresponds to genes
similarly altered by 0.02% MMS and 170 Gy of ionizing
radiation (Gasch et al., 2001) (Figure S3D and Table S2).
RT-PCR analysis of three well-characterized DNA damage-
induced transcripts confirmed that they are not induced by
hormetic menadione treatment (Figure 4C). Instead, further
characterization of menadione-induced genes identified
several involved in oxidative stress responses that were
elevated in wild-type, but not rph1D, strains (AHP1, CTA1,
CUP1-1, LOT6, MXR1, TRX1, TRX2, TRX3, TSA1, and YPR1).
Collectively, these likely explain the hormetic decrease in
ROS observed at day 1 of CLS (Figure S3E and Table S2).
Furthermore, although menadione treatment extends CLS via
modulating mtROS levels (Figure 2), hormetic menadione
treatment did not induce oxidative DNA damage in a wild-
type strain or an ogg1D strain that lacks the oxidized purine
repair enzyme and is therefore hypersensitive to oxidative
DNA damage (Karahalil et al., 1998) (Figure 4D). Finally, mtROS
adaptation does not require DNA double-strand break
detection or signaling mediated by Mre11p, a component
of the MRN/MRX complex (Nakada et al., 2004) (Figure S3F).
Together, these data support that mtROS produced during
hormetic menadione treatment activates specific DNA
damage response kinases without inducing oxidative nuclear
DNA damage or a canonical nuclear DNA damage response.964, June 4, 2013 ª2013 Elsevier Inc. 957
Figure 4. mtROS Activate a Noncanonical, Tel1p-Dependent DNA
Damage Response
(A) Left: western blot analysis of Rad53p phosphorylation in the wild-type
treated with 50 mMmenadione (MD+), 0.01% methylmethane sulfate (MMS+),
or ethanol () for 30 min. Right: wild-type and tel1D strains treated with
menadione, MMS, ethanol, and/or calf intestinal phosphatase (CIP).
(B) Protein phosphorylation at (S/T)Q sites in response to 30min treatment with
50 mM menadione or 0.01% MMS. Molecular weights (kDa) are indicated on
the left. Starred bands indicate proteins that are phosphorylated in response to
MMS, but not menadione, treatment.
(C) RT-PCR of transcripts induced by DNA damage.Wild-type and rph1Dwere
treated with 50 mM menadione (MD), 0.01% MMS, or vehicle (nt) for 30 min in
exponential phase. See also Table S2.
(D) Quantification of 8-hydroxyguanosine (8-oxoG) formation in wild-type and
ogg1D. Cells were treated for 30 min prior to DNA extraction. Values were
normalized to untreated wild-type, which was set to 1. Data points represent
the mean of three biological replicates inoculated from single colonies ± SEM.
‘‘ns’’ designates p > 0.05, *p% 0.05, **p% 0.01. See also Figure S3.
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958 Cell Metabolism 17, 954–964, June 4, 2013 ª2013 Elsevier Inc.Hormetic mtROS Signaling Inactivates Rph1p to Alter
Subtelomeric Chromatin
Rad53p-dependent phosphorylation of Rph1p causes it to
dissociate from chromatin, elevating H3K36me3 levels to regu-
late transcription (Figure 5A) (Liang et al., 2011). We examined
Rph1p phosphorylation in response to mtROS and found that
hormetic menadione treatment induces a partial Rph1p upward
mobility shift relative to treatment withMMS (Figures 5B, left, and
S4A), mirroring the partial activation of Rad53p under these con-
ditions (Figure 4A). Rph1p phosphorylation in response to mena-
dione, but notMMS, also required Tel1p andRad53p (Figure 5B).
These data show that mtROS signaling via Tel1p and Rad53p in-
duces phosphorylation of Rph1p, which may subsequently alter
the chromatin binding capacity of Rph1p and H3K36me3 levels.
In yeast, histonemethylation and acetylation contribute to het-
erochromatin formation at the ribosomal DNA (rDNA) gene clus-
ter, mating loci, and subtelomeric regions (defined as within 25
kb of telomeric repeat DNA) (Barton and Kaback, 2006; Dang
et al., 2009; Millar and Grunstein, 2006; Santos-Rosa et al.,
2004). Yeast deficient in heterochromatin formation at these
silenced loci exhibit decreased replicative lifespan (Dang et al.,
2009; Kaeberlein et al., 1999), yet it is unknown how silencing
at these regions influences chronological aging. H3K36me3 is
implicated in both transcriptional repression and activation
within euchromatic regions (Wagner and Carpenter, 2012), but
the role of this modification at silenced loci has not been
described. Since Rph1p phosphorylation regulates its chromatin
binding capacity (Liang et al., 2011) and Rph1p is phosphory-
lated in response to mtROS (Figure 5B), we investigated whether
mtROS signaling altered the association of Rph1p with silenced
regions of the yeast genome. Chromatin immunoprecipitation
(ChIP) of Rph1-HA at day 1 of CLS (when adaptive response to
menadione would be evident; Figure S4B) revealed that, in the
absence of hormetic menadione treatment, Rph1p binding at
all examined silenced geneswas enhanced relative toACT1 (Fig-
ures 5C and S4C). However, Rph1p binding at subtelomeric re-
gions was specifically altered in response to hormetic mtROS
signaling in a manner dependent on Rad53p (Figures 5C and
S4C). Consistent with loss of Rph1p, H3K36me3 levels
increased at subtelomeric genes in an mtROS- and RPH1-
dependent manner, suggesting that mtROS signaling regulates
the H3K36me3 demethylase activity of Rph1p (Figures 5D and
S4D). The requirement for H3K36 demethylation in adaptive
CLS extension is specific to Rph1p, as deletion of Jhd2p, which
also demethylates di- and trimethyl H3K36 (Tu et al., 2007), did
not affect mtROS adaptation (Figure S4E). These data suggest
that, although Rph1p may function at several silenced regions
in chronologically aged yeast, hormetic mtROS signaling via
Rad53p specifically targets Rph1p activity at subtelomeric re-
gions, eliciting epigenetic changes that promote lifespan
extension.
Signaling by mtROS Represses Transcription of
Subtelomeric Genes
We next investigated the adaptive transcriptional consequences
of Rph1p-mediated epigenetic changes in response to mtROS
signaling. We performed gene expression microarrays of wild-
type and rph1D yeast, that had been treated with menadione or
a vehicle control during exponential growth, at day 1 of CLS. To
Figure 5. mtROS Regulate Rph1p to Modify
Subtelomeric Heterochromatin
(A) Schematic of Rad53p-dependent regulation of
Rph1p chromatin binding and histone demethy-
lase activity.
(B) Western blot analysis of Rph1-HA phosphory-
lation inwild-type, tel1D, andsml1D/rad53D strains
treated with 50 mM menadione or 0.01% MMS.
Samples for western blots were collected after
30 min of treatment during exponential growth.
(C) ChIP of Rph1-HA at a control region (ACT1) and
two subtelomeric genes (YPS6 and YEL077C) in
a wild-type or sml1D/rad53D background at day 1
of CLS. Data points represent the mean of two
independent ChIP experiments; error bars repre-
sent the range. Valueswere normalized to thewild-
type untreated ACT1 sample, which was set to 1.
(D) ChIP using antibodies against trimethyl H3K36
or total H3 in wild-type or rph1D as in (C). See also
Figure S4.
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we excluded transcripts that were altered in an rph1D strain
treatedwithmenadione.Additionally,wecompared the remaining
transcripts with those altered in an untreated rph1D strain. Since
mtROS signaling to Rad53p essentially inactivates Rph1p deme-
thylase activity, we reasoned that although Rph1p has mtROS-
independent functions (Orzechowski Westholm et al., 2012), a
null strain might reveal a subset of the transcriptional outcomes
relevant to mtROS-mediated CLS extension. Gene list compari-
sons (Table S3) are summarized in Figure 6A. We observed
3-fold enrichment for the Rph1p binding motif (WAG4) among
transcripts induced by bothmtROS signaling and Rph1p deletion
(sector C; Figure S5A), consistent with the involvement of Rph1p
in regulating gene induction following hormetic mtROS signaling.
mtROS signaling specifically affects Rph1p binding at subtelo-
meric regions (Figure 5C), and subtelomeric transcripts were en-
riched only among genes repressed by mtROS signaling and
RPH1 deletion (sectors A and C; Figures 6B, S5B, and S5C and
Table S4). Using a subtelomeric URA3 reporter and RT-PCR,
weconfirmed that adaptivemtROSsignaling represses transcrip-
tion from subtelomeric regions (Figures S5D and S5E), but not at
other silenced regions (Figure S5F and Table S5). Together, these
results indicate that hormetic mtROS signaling to Rph1p selec-
tively silences subtelomeric transcription.
Hormetic mtROS Signaling Modifies Higher-Order
Chromatin Structure to Extend CLS
Histone modifications at subtelomeric regions can influence
higher-order chromatin formation, which determines geneCell Metabolism 17, 954–expression (Schoeftner and Blasco,
2009). The Sir complex is initially re-
cruited to silenced regions via Sir2p-
mediated histone deacetylation (Rusche
et al., 2003). This enhances the binding
of Sir3p, which recruits additional Sir2p
to nucleate heterochromatin spreading
(Norris and Boeke, 2010). Histone
methylation can enhance Sir3p binding,thereby influencing transcriptional silencing (Ng et al., 2002).
ChIP experiments revealed that treatment with menadione dur-
ing exponential growth strongly enhanced the association of
Sir3p with subtelomeric regions in a wild-type strain, but not in
an rph1D strain, at day 1 of CLS (Figure 7A). Sir3p binding was
not similarly affected at other silenced loci (Figure S6A). Addi-
tionally, Sir3p was required for subtelomeric silencing following
mtROS signaling (Figure 7B); however, at other silenced loci,
menadione-induced transcriptional changes were mainly Sir3p
independent (Figure S6B). Finally, hormetic mtROS signaling
failed to extend CLS of a sir3D strain (Figures 7C and S6C).
These findings demonstrate that Rph1p-regulated subtelomeric
silencing, mediated by Sir3p, is a key outcome of hormetic
mtROS signaling that extends lifespan.
DISCUSSION
Mitochondria, epigenetics, and telomere function have all been
independently implicated in lifespan regulation. Our investigation
of mitochondrial stress signaling in yeast demonstrates coordi-
nation among these processes to promote lifespan extension.
Specifically, we have elucidated a mitochondria-to-nucleus
signaling pathway (Figure 7D) in which the DNA damage kinase
Tel1p transduces an mtROS signal to activate Rad53p, which in
turn regulates the ability of the histone demethylase Rph1p to
bind subtelomeric chromatin. The loss of Rph1p from subtelo-
meric chromatin elevates H3K36me3 and enhances binding of
the silencing protein Sir3p to repress subtelomeric transcription.
Sir3p-mediated subtelomeric silencing is an essential outcome964, June 4, 2013 ª2013 Elsevier Inc. 959
Figure 6. Hormetic mtROS Signaling to Rph1p Promotes Subtelo-
meric Silencing
(A) Gene expression changes induced by exponential phase menadione
treatment in a wild-type strain (mtROS dependent, sector A), rph1D strain
(Rph1p dependent, sector B), or mtROS-dependent inactivation of Rph1p
(sector C) at day 1 of CLS. Gray font indicates the number of induced genes,
and black font indicates the number of repressed genes. See Table S3 for full
gene lists.
(B) Repressed genes located the indicated distance (kb) from telomeres.
Subtelomeric genes are within 25 kb (gray region) of telomeres and are listed in
Table S4. The significance of enrichment of repressed subtelomeric geneswas
determined using hypergeometric probability distribution. See also Figure S5.
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Although heterochromatin maintenance at several loci influ-
ences yeast lifespan (Dang et al., 2009; Kaeberlein et al.,
1999), mtROS signaling specifically targets subtelomeric hetero-
chromatin. We propose that this specificity is a key component
of the mtROS hormetic response and corroborates previous
studies in which Sir proteins target distinct genomic regions un-
der different conditions, with unique consequences for chrono-
logical and replicative aging (Ruault et al., 2011; Salvi et al.,
2013). For example, sir2D enhances CLS extension under caloric
restriction or in sch9D strains by inducing stress response and
metabolic genes that promote longevity (Fabrizio et al., 2005)
but shortens RLS due to a failure to maintain heterochromatin
at the rDNA cluster (Kaeberlein et al., 1999).
Subtelomeric and telomeric heterochromatin maintenance
preserves telomere length and genomic stability in yeast and
mammals (Schoeftner and Blasco, 2009). Telomere function is
intimately connected with health- and lifespan but is most often
associated with replicative senescence. Our finding that altered
subtelomeric silencing supports CLS extension implies that telo-
mere function regulates postmitotic cellular health and aging. At
this point, it is unclear how repressing subtelomeric transcription
extends CLS. Transcription of subtelomeric coding or noncoding
genesmay limit lifespan by alteringmetabolism, telomere length,960 Cell Metabolism 17, 954–964, June 4, 2013 ª2013 Elsevier Inc.or general transcription (Pryde and Louis, 1997; Schoeftner and
Blasco, 2009; Smith et al., 2011; Yamada et al., 1998). Alterna-
tively, increased telomere packaging would both repress tran-
scription and protect telomeres from DNA damage-induced
attrition, which can lead to gross chromosomal rearrangements
that destabilize the nuclear genome (Davoli and de Lange, 2011).
We propose that hormetic mtROS stimulate pre-emptive telo-
mere and subtelomere heterochromatin formation early in life,
which minimizes telomeric DNA damage and maintains genomic
stability during aging.
Although epigenetic outcomes are essential to the adaptive
response, our data also indicate that transcriptional changes
mediated by Msn2p/Msn4p, Gis1p, and Rph1p support mtROS
adaptation. Menadione treatment induces a number of oxidative
stress response genes in a manner dependent on Rph1p,
which may account for the hormetic decrease in ROS during
post-diauxic and stationary phases (Figure S3E and Table
S2D). All of the candidate mtROS-responsive proteins we inves-
tigated bind a similar DNA motif (Figure 1B), and since all
proteins are at least partially required for mtROS adaptation
(Figure S1), we speculate that Rph1p-dependent chromatin re-
modeling might facilitate Msn2p/Msn4p- and/or Gis1p-medi-
ated transcription at mtROS-responsive genes. Future studies
to explore the relationship between Rph1p, Msn2p/Msn4p,
and Gis1p in transcriptional regulation and mtROS hormesis
may uncover additional cooperation among these proteins in
lifespan regulation.
Our results also indicate that Tel1p propagates an mtROS
signal in the absence of nuclear DNA damage (Figures 4C, 4D,
S3E, and S3F), which suggests that certain DNA damage
response kinases function as both ROS and DNA damage sen-
sors, and can regulate distinct cellular processes in a stimulus-
specific manner. Recent studies show that ATM (the mammalian
homolog of Tel1p) acts as a redox sensor (Guo et al., 2010). Our
finding that Tel1p mediates the hormetic mtROS response in
yeast suggests that this function is evolutionarily conserved.
Hormetic mtROS signaling ultimately inhibits the chromatin
binding capacity of the histone demethylase Rph1p at subtelo-
meres, thereby increasing H3K36me3 at these regions (Figures
5C and 5D). Although the role of histone acetylation in transcrip-
tional silencing at subtelomeres is well established (Dang et al.,
2009; Kozak et al., 2010; Santos-Rosa et al., 2004), it is increas-
ingly evident that histone methylation can also contribute to this
process in both yeast and mammals (Blasco, 2007; Caslini et al.,
2009; Dang et al., 2009; Kozak et al., 2010; Santos-Rosa et al.,
2004). Thus, it will be important to determine which methyltrans-
ferases and demethylases function at subtelomeres during
mammalian aging. Our study would support members of the
Jumonji-domain demethylases related to yeast Rph1p as prime
candidates.
In conclusion, our results provide insight into multiple aspects
of aging by integrating mtROS, DNA damage signaling, telo-
meres, and epigenetics into a prolongevity pathway. The mtROS
signaling pathway identified herein connects mitochondria and
telomere functional status and supports recent findings that
these processes likely do not regulate aging in isolation (Sahin
et al., 2011). The hormetic mtROS signaling pathway we
describe should provide a platform for more integrated network
theories of aging and lifespan regulation.
Figure 7. mtROS Signaling via Rph1p Pro-
motes Sir3p Binding at Subtelomeres to
Repress Gene Expression and Extend CLS
(A) ChIP of Sir3p inwild-type (DBY2006) and rph1D
at a control region (ACT1) and two subtelomeric
genes (YPS6 and YEL077C). Cells were analyzed
at day 1 of CLS following treatment with 50 mM
menadione or vehicle during exponential growth.
(B) Quantitative RT-PCR of subtelomeric tran-
scripts relative to ACT1 at day 1 of CLS in wild-
type or sir3D yeast following 50 mM menadione or
vehicle during exponential growth.
(C) CLS of wild-type and sir3D treated with 50 mM
menadione (MD) or vehicle (nt) during logarithmic
growth.
(D) Model for mtROS signaling via DNA damage
response kinases and Rph1p to regulate sub-
telomeric heterochromatin formation and CLS.
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Yeast Strains
All strains used in this study are derivatives of DBY2006 (MATa his3-D200 leu2-
3,-112 ura3-52 trp1-D1 ade2-1) and are listed in Table S7. Deletion strains
were generated via gene replacement with URA3, KanMX6, or hphMX3 cas-
settes and transformed using the lithium acetate method (Gietz and Schiestl,
2007). Endogenous RPH1 was tagged at the C terminus with a HA-KanMX6
cassette (Longtine et al., 1998). To generate the SOD2 overexpression strain
(Figure S3D), the endogenous SOD2 promoter (600 to 1) was replaced
with the TDH3 promoter (Ko¨tter et al., 2009). All strains were verified by PCR.
Chronological Lifespan Measurement
Yeast were grown in minimal dextrose medium supplemented with essential
amino acids (Sherman, 1991). For lifespan assays, saturated cultures from sin-
gle colonies were diluted to an optical density 600 (OD600) of 0.01 in 50ml fresh
media and grown at 30C, 200 rpm until the OD reached 0.5. Either menadione
(50 mM final concentration; Sigma-Aldrich) or an equivalent volume of ethanol
(no treatment control) was added, and cultures were grown until the OD
reached 2.0. At this point, cells were pelleted and resuspended in media
from an untreated parallel culture. CLSwas determined by trypan blue staining
as described (Bonawitz et al., 2006). Measurements were initiated at day 2 of
CLS. All strains and treatments were analyzed in triplicate. To quantitatively
compare CLS extension between different strain backgrounds, the area under
the viability curve was calculated in GraphPad Prism. The difference between
the untreated and menadione-treated wild-type areas was set to 1, and differ-
ences within strain backgrounds are expressed as percent of wild-type CLS
extension.
Chemical Toxicity
Wild-type yeast were grown to an OD600 of 0.5 and treated with 50 mMmena-
dione, 200 mMmenadione, 0.01%MMS, 0.02%MMS, or ethanol (vehicle con-Cell Metabolism 17, 954–trol). Cell growth was monitored for 24 hr of treat-
ment, and viability was assessed via trypan blue
staining.
Flow Cytometry
Measurement of cellular superoxide using dihy-
droethidium (DHE) was performed as described
(Bonawitz et al., 2007; Pan et al., 2011).
Immunoblotting
Yeast whole-cell extracts were prepared from
cells in exponential growth phase treated with
menadione, MMS (0.01% final concentration), or
ethanol for 30 min (Keogh et al., 2006). Proteins
were separated in 6% SDS-PAGE gels (to resolveRad53p and Rph1-HA phosphorylation) or 12% SDS-PAGE gels and trans-
ferred to polyvinylidene fluoride (PVDF) membranes (Millipore). Blocking and
antibody incubations were carried out in Tris-buffered saline and Tween
(TBST; 10 mM Tris [pH 8.0], 150 mM NaCl, 0.05% Tween 20) containing 5%
nonfat dry milk. Membranes were incubated with anti-Rad53 (1:300; Santa
Cruz Biotechnology), anti-phospho-(S/T)Q (1:1000; Cell Signaling), anti-
MnSOD (1:500; Assay Designs), anti-HA (1:1000; Covance), anti-actin
(1:1000; Chemicon), or anti-GAPDH-HRP (horseradish peroxidase) (1:1000;
Abcam). Immunoblotting was performed on protein isolated from at least
two independent experiments. Band density traces and quantification were
determined using ImageJ (National Institutes of Health).
8-Hydroxyguanosine Quantification
Yeast cultures in exponential growth phase were treated with ethanol, 50 mM
menadione, or 200 mMmenadione for 30min prior to DNA extraction (Hoffman,
2001). Total DNA was treated with ribonuclease (RNase) A and proteinase K
(Sigma-Aldrich) and then precipitated with phenol:chloroform and ethanol.
DNA (5 mg per sample) was blotted onto a nitrocellulose membrane. The mem-
brane was dried for 1 hr at 85C, blocked in TBST with 5% BSA (Sigma-
Aldrich), and incubated overnight in anti-8-hydroxyguanosine (Chemicon)
diluted 1:500 in BSA-TBST. After washing in TBST, the membrane was incu-
bated in HRP-conjugated anti-goat secondary at a 1:2000 dilution for 1 hr
and visualized with SuperSignal West Pico Chemiluminescent Substrate. To
normalize dot intensity to total DNA, the membrane was incubated in 2.5 mg
DAPI and visualized on a VersaDoc imager (Bio-Rad). Antibody and DAPI
dot intensity from triplicate independent treatments were quantified using
ImageJ.
RNA Preparation and Microarray Analysis
RNA extraction and purification were performed as described (Bonawitz
et al., 2008) from wild-type DBY2006 and rph1D cultures grown for 2 or
24 hr after addition of 50 mM menadione or ethanol. RNA quality bioanalysis,964, June 4, 2013 ª2013 Elsevier Inc. 961
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Gen 12 3 135 K array were performed in collaboration with the Yale Univer-
sity W.M. Keck Foundation Biotechnology Resource Laboratory according to
the manufacturer’s protocol. Two independent biological replicates were
prepared for each sample, and hybridization was performed in duplicate to
generate technical replicates. Raw data were normalized accordinig to the
Robust Multi-array Average (RMA) algorithm using NimbleScan software
(Irizarry et al., 2003). Probe expression values were used to determine fold
change and filtered to significantly induced and repressed probe lists (p %
0.01 as determined by Student’s t test). Gene lists were generated based
on the occurrence of at least two probes for a particular gene present exclu-
sively in induced or repressed probe lists. To map the chromosomal location
of genes in sectors A, B, and C, the distance from the transcription start site
to the nearest telomere was determined. Gene lists are described in the Ta-
bles S2 and S3.
Normalized expression data were downloaded from the Gene Expression
Omnibus at NCBI (GSM1102, record GDS108 [Gasch et al., 2000]) and from
the supplemental online material associated with Hardwick et al. (1999).
Gene lists were ranked according to fold change, and the top 5% induced
genes were selected for further analysis to identify genes induced in both
data sets. The coinduced genes were further analyzed using WebMOTIFS
(Romer et al., 2007) and YEASTRACT (yeast search for transcriptional regula-
tors and consensus tracking; Abdulrehman et al., 2011) to generate the data
shown in Figure 1C.
Quantitative RT-PCR
RNA was isolated as described above and converted to cDNA using the High
Capacity cDNA Reverse Transcription Kit (Agilent) according to the manufac-
turer’s instructions. cDNA was diluted 1:10, and each 20 ml reaction contained
10 ml diluted cDNA, 0.4 ml dilutions of each primer (from a 25 mM stock), and
9.2 ml Bio-Rad iQ SYBR Mix. PCR conditions were as described (Cotney
et al., 2007).
Chromatin Immunoprecipitation
Yeast cultures were treated with 50 mM menadione or ethanol from OD 0.5 to
OD 2.0. At 24 hr after the initiation of menadione treatment at OD 0.5, cells
were processed for ChIP analysis, which was performed essentially as
described (Aparicio et al., 2004), with the following modifications. DNA was
sheared in a Bioruptor UCD-200 Sonicator at 4C five times for 20 s each.
Chromatin was precleared by incubating with protein A agarose beads (Milli-
pore) for 30 min at room temperature. Antibodies used were anti-HA (Cova-
nce), anti-trimethyl H3K36 (Epigentek), anti-H3 (Abcam), and anti-Sir3 (Santa
Cruz Biotechnology). Quantitative PCR of three technical replicates per sam-
ple was performed using the same conditions described for RT-PCR, except
the reaction proceeded for 40 cycles. Primers are listed in Table S8.
Statistical Analysis
For CLS, fluorescence-activated cell sorting (FACS), 8-hydroxyguanosine, and
RT-PCR analysis, all data points represent the mean of biological triplicate
samples inoculated from isolated single colonies. Error bars represent SEM.
p values were determined using Student’s unpaired t test, and values for rele-
vant comparisons are indicated within figures. Statistical analysis for enrich-
ment of subtelomeric transcripts was determined using a hypergeometric
probability distribution (Martin et al., 2004). For ChIP analysis, data points
represent the mean of two biological replicate samples inoculated from iso-
lated single colonies. Error bars represent the range.ACCESSION NUMBERS
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